Uncategorized @au Archives - Laborie

Uncategorized @au

Laborie Appoints Chris Smith as Chief Executive Officer

Laborie Medical Technologies Corp., a global leader in medical technology, today announced the appointment of Chris Smith as Chief Executive Officer, effective September 22, 2025. Smith succeeds Michael Frazzette, who announced his retirement last month.

Uncategorized @au |

Urology & Urogynecology

Optilume® BPH Catheter System Issued Category 1 CPT Code by American Medical Association

laborie for dignity for life and brighturo a brighter future

Uncategorized @au

Laborie Medical Technologies Invests in Medical Technology Start-Up Bright Uro

Laborie Medical Technologies  announced a strategic equity investment in Bright Uro, an early-stage medical technology company headquartered in Irvine, CA.

Uncategorized @au |

Urology & Urogynecology

Laborie Medical Technologies Acquires Urotronic

Urotronic joins Laborie as part of a long-term growth strategy for the Portsmouth-based medical device company. Urotronic’s Optilume® BPH Catheter System, a unique minimally invasive surgical therapy (MIST), is a paradigm shift for patients and clinicians in global interventional urology.

Uncategorized @au |

Urology & Urogynecology

Laborie Medical Technologies Announces Agreement to Acquire Urotronic for up to $600 Million

Acquisition expands urology portfolio and demonstrates Laborie’s commitment to providing proven, innovative solutions to physicians and patients globally

Uncategorized @au

Laborie Transitions Urology and Gastroenterology Sales Model in Australia

Uncategorized @au

Laborie’s Optilume® Technology Receives UK NICE Guideline Recommendations

AQlt

Uncategorized @au

Laborie Medical Technologies Unveils New Brand

Uncategorized @au

LABORIE Medical Technologies Enters into Strategic Partnership with Urotronic

Uncategorized @au

LABORIE NAMES MICHAEL FRAZZETTE AS NEW PRESIDENT AND CEO

Page 1 of 212 »